Newsfeeds - Spark Newswire

1 minute read

Greenwich LifeSciences To Implement Stock Repurchase Program For Up To $10M; Co. Also To Extend Lock-up Of Insiders For An Additional 1 Year

Today, 10:13 AM

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients

GLSI

5 minute read

58 Biggest Movers From Friday

By Lisa Levin

Today, 10:13 AM

Gainers Hagerty, Inc. (NYSE: HGTY) shares jumped 46.5% to close at $15.62. TuanChe Limited (NASDAQ: TC) gained 44.7% to settle at $3.30.

AIH

4 minute read

Greenwich LifeScience Provides Clinical Updates On Upcoming Phase III Clinical Trial, FLAMINGO-01

By Bill Haddad

Today, 10:13 AM

- The GP2 Phase III clinical trial design was presented in a poster during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, providing an open label arm and potentially valuable data that can be

GLSI

2 minute read

News

Greenwich LifeSciences Provides Updates On Recent And Upcoming Developments

By Benzinga Newsdesk

Today, 10:13 AM

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who

GLSI